HRA promotes morning-after manners
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Empowering both men and women to make responsible choices when it comes to contraception is the aim of a new educational campaign from HRA Pharma in support of its EllaOne (ulipristal acetate) emergency contraceptive in the UK.
You may also be interested in...
HRA Pharma Reveals Big Growth Ambitions In Quest To Become Top-10 OTC Player
A combination of prescription-to-OTC switches, acquisitions and maximising the potential of its existing portfolio will take France’s HRA Pharma to the next level, reveals chief commercial officer Martyn Hilton.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.